Ignite Creation Date:
2025-12-26 @ 11:11 PM
Ignite Modification Date:
2026-03-01 @ 8:57 PM
Study NCT ID:
NCT04667312
Status:
COMPLETED
Last Update Posted:
2023-10-02
First Post:
2020-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-24
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-27
First Submit QC Date:
None
Study First Post Date:
2020-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-29
Last Update Post Date:
2023-10-02
Last Update Post Date Type:
ACTUAL